… To identify long-term asthma-related QoL outcomes associated with omalizumab therapy
in patients with moderate-to-severe asthma, we developed a systematic review according to …

… of omalizumab therapy in severe allergic neous injections at a dose determined from the
prescribasthma, … zumab treatment in severe allergic asthma: the South-Eastern 17. Humbert M, …

… omalizumab for moderate-to-severe allergic asthma in the US in 2003 and for severe allergic
asthma … to evaluate the effectiveness of omalizumab add-on therapy under conditions of …

… and pulmonology centers allowed to initiate omalizumab treatment for uncontrolled
allergic-asthma patients, according to Turkish drug reimbursement rules, were invited to participate …

… we report on long-term outcomes of omalizumab treatment. We collected data from our severe
asthma registry on hospitalisations, exacerbations, corticosteroid sparing, asthma control, …

… Our findings may further support the idea that long-term omalizumab treatment is safe
also in patients with previous cancer, since it does not increase the risk of relapse. …

… We retrospectively reviewed data of all severe asthma patients who were treated with
omalizumab … Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled …

… In fact, discontinuation of a long-term treatment with omalizumab is often followed within
a few months by an increased serum … Am J Respir Crit Care Med 2013; 187: 804–811. …

… -years of exposure (Unpublished data, Omalizumab Periodic Safety Report [PSUR], Novartis…
severe allergic asthma (SAA) has shown the short- and long-term efficacy of omalizumab by …

… Albeit in this cohort of patients, the present study provides evidence for the continued
efficacy of omalizumab in the very long term in treatment of severe persistent allergic asthma. …